Journal Information

Instructions for authors

INTRODUCTION

The Brazilian Journal of Anesthesiology/ Revista Brasileira de Anestesiologia (BJAN) is the official journal of the Brazilian Society of Anesthesiology (SBA), which supports the journal completely – the cost of publishing is on behalf of the Society, with no charges to authors.

The BJAN publishes original work in all areas of anesthesia, surgical critical care, perioperative medicine and pain medicine, including basic, translational and clinical research, as well as education and technological innovation. In addition, the Journal publishes pictorial and systematic reviews, relevant case reports, clinical images, clinical reports, editorials and letters to the editor. Special articles such as guidelines and historical manuscripts are published upon invitation only, and authors should seek subject approval by the Editorial Office before submission.

Before submitting a manuscript, authors should read the present Instructions to authors carefully and adhere to them. Manuscripts must be submitted electronically via the Journal’s online submission system <http://www.evise.com/evise/jrnl/BJAN> and receipt will be acknowledged by e-mail. Problems with submissions should be reported to the Editorial Office. Decisions on submissions are final and will take place in approximately eight to 12 weeks.

The BJAN accepts only original articles that are not under consideration by any other journal and that have not been published before, except as academic theses or abstracts presented at conference or meetings. A cloud-based intuitive platform is used to compare submitted manuscripts to previous publications, and submissions must not contain any instances of plagiarism. Authors must obtain and send the Editorial Office all required permissions for any overlapping material and properly identify them in the manuscript to avoid plagiarism.

All articles submitted for publication are assessed by two or more members of the Editorial Board or external peer reviewers, assigned at the discretion of the Editor-in-chief or the Associate editors.

All editorial communications should be addressed to the Editor-in-Chief.
E-mail: editor.bjan@sbahq.org

Types of article

Articles must follow the specifications presented below regarding the maximum number of words in the manuscript and abstract, references, tables, and figures, as well as the format of the abstract.

Type of manuscript Words References Tables or figures Abstract
Clinical research 3,000 30 6 Structured up to 250 words
Systematic review 4,000 60 6 Structured up to 250 words
Pictorial review 3,000 30 12 Unstructured up to 250 words
Narrative review 4,000 100 4 Unstructured up to 250 words
Case reports 1,500 5 2 Unstructured up to 100 words
Letter to the Editor 1,000 5 1 No
Clinical images 200 3 3 No
Editorials 2,000 20 2 No
  • Clinical research: primary clinical, observational or experimental research information. Each kind of study will contain different elements. Authors can include supplementary material for exclusive online publication, and such material should be part of the submission letter. A copy or link of the ethical approval of the study, as well as its registry, must be submitted along with the manuscript. For a list of registry platforms for clinical trials, assess: <http://apps.who.int/trialsearch/>. Brazilian researchers are advised to register at ReBEC: . Keep reading for additional details regarding ethical requirements for publishing.
  • Narrative review: as a rule, narrative reviews are written by invitation from the Editor-in-chief. If you were not invited, before submitting a review you should contact the Editor-in-chief, who will evaluate the appropriateness of the proposal to the Journal, avoiding publishing duplications. Systematic review, as well as scoping review, rapid review, state of art review and overview of reviews can be considered for publication.
  • Systematic reviews: authors should register the review protocol in PROSPERO (International Prospective Register of Systematic Reviews). Also, authors must state the review protocol in the Methods section and indicate where it can be accessed. Summarize sections by pulling together the implications of main findings, avoiding just the repetition of the results of previously published studies, searching for an expanded evidence-based conclusion. Incorporating the results of a new study with previous relevant studies in a meta-analysis is encouraged.
  • Case reports: BJAN only accepts for publication clinical information or case reports that describe innovations, novelties or new clinical approaches for already established clinical problems. They must contain impactful information, other than just the introduction of techniques, methods or medical devices. A copy of the Institutional Research Board approval must be submitted along with case reports. If any kind of patient image is used, it must be unidentified and anonymized and a specific signed authorization for publication should be obtained from the patient, legal guardians or family and submitted along with the report.
  • Letter to the editor: Letters to the editor should include constructive, obje-ctive and educational comments on already published BJAN papers or be “freestanding”. Reporting research findings or cases reports as letters to the editor is not advised. “Freestanding” letters to the editor may discuss matters of interest to readers without linkage to papers already published in BJAN. Letters will be published at the sole discretion of the Editor-in-chief.

Language

English is the official language of BJAN, which receives submissions in English and Portuguese. After acceptance, articles will be published both in English and Portuguese.

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in the Instructions to Authors document for more details.

Ensure that the following items are present at submission:

  • Cover letter;
  • Title page;
  • Designation of the corresponding author with contact details: e-mail address; Full postal address; ORCID iD;
  • All authors must have an e-mail, ORCID and their Elsevier profile updated with this information. Learn more about ORCID above in this document;
  • Copy or link for the Institutional Research Board approval of the submission, if applicable
  • The link for the study registry, if applicable;
  • Upload of all specific files for the study design: abstract including keywords; manuscript including references; all figures (including relevant captions); all tables (including titles, description, footnotes) – ensure all figure and table citations in the text match the files provided –; supplemental files (where applicable);
  • Manuscript has been “spell checked” and “grammar checked”;
  • All references mentioned in the Reference List are cited in the text, and vice versa;
  • Completed reporting guideline checklist;
  • Link for the data repository, if applicable;
  • Permission has been obtained for use of copyrighted material from other sources (including the Internet);
  • Relevant declarations of interest have been made.

BEFORE YOU BEGIN

Ethics in publishing

Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.

The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals <http://www.icmje.org/icmje-recommendations.pdf> and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly. It is recommendable to use the words “male” and “female” (and other sexes/genders as appropriate) when speaking about a patient’s sex. The numbers and percentages of both male, female and other sexes/genders must be reported in the text and/or tables. The manuscript must contain data on the age (mean with range), height (m), weight (kg), sex, criteria for selection, health conditions, among others that are significant to study results. It is better to present more complex information in a table to facilitate the understanding of the data.

  • Informed consent and patient details: Studies on patients or volunteers require Institutional Ethical Committee or Internal Review Board (IRB) approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained when an author wishes to include case details, other personal information or images of patients or any other individuals.
  • If any kind of patient image is used, it must be deidentificated and anonymized, and a specific signed authorization for publication should be obtained from the patient, legal guardians or family and submitted along with the manuscript or case report. Unless you have written permission from the patient or patient’s relatives (when applicable), personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
  • The author must retain written consents before submitting the article, but copies should not be provided to the journal. If specifically requested by the journal in exceptional circumstances (for example, if a legal issue arises), the author must provide copies of the consents or evidence that such consents have been obtained.

Reporting guidelines

BJAN mandates the use of an appropriate reporting guideline when writing any health research manuscript. Guidance on each type of study can be found on the EQUATOR (Enhancing the Quality and Transparency Of health Research) Network website <http://www.equator-network.org/> or below in the section “What reporting guideline to use”.

Authors must submit completed checklists for the relevant reporting guidelines (and flow diagram if applicable) that they followed along with the manuscript, indicating the manuscript page on which each checklist item is found. Editable checklists for reporting guidelines can be found on the EQUATOR Network website, which also gives general information on how to choose the correct reporting guideline and why the guidelines are important. Using a checklist helps to ensure that the reporting guideline was used correctly.

Your article should report at least the content addressed by each item of the identified checklist or state that the item was not considered in the study and, if relevant, the reason why not (for example, if you did not use blinding, your article should explain it). Meeting these basic reporting requirements will greatly improve the value of your manuscript, may facilitate/enhance the peer review process, and may enhance its chances for eventual publication.

Checklists are not simply an administrative hurdle. We ask you to complete a checklist because this helps you to notice if you have not included all the important information in your article, and because it helps our editors and reviewers to complete the same check. If the checklist indicates an item that you have not addressed in your manuscript, please either explain in the manuscript text why this information is not relevant to your study or add the relevant information.

What reporting guideline to use

  • Use the CARE guideline for reporting one case study or a series of case studies
  • Use the CONSORT guideline or one of its extensions:
    • If you selected your participants before they received the intervention/exposure/etc. under study, AND
    • You controlled which intervention/exposure/etc. they each received, AND
    • You used a random allocation method to decide which intervention/exposure/etc. they each received.
    i.e.: a randomized controlled trial.
  • Use the STROBE guideline or one of its extensions:
    • If you selected your participants after they received the intervention/exposure/etc. under study, OR
    • You selected your participants before they received the intervention/exposure/etc. under study AND you did not control which intervention/exposure/etc. they received (they decided/their doctor decided/life just happened).
    i.e.: an observational study.
  • Use the TREND guideline:
    • If you selected your participants before they received the intervention/exposure/etc. under study, AND
    • If CARE, CONSORT, and STROBE are not applicable to your research AND
    • you used a non-random way to decide which intervention/exposure/etc. your participants received, such as which hospital they went to or what their clinical symptoms were.
    i.e.: a non-randomized trial.
  • If you are reporting a protocol.
    • Use the SPIRIT guideline for the protocol of a clinical trial.
    • Use the PRISMA-P guideline for the protocol of a systematic review
  • If you are reporting a literature review:
    • Use the ENTREQ guideline for a review of studies that use descriptive data, such as unstructured interviews (qualitative data).
    • Use the MOOSE guideline for a review of observational studies.
    • Use the PRISMA guideline for any other kind of systematic review or meta-analysis.
  • If you are reporting on animal research:
    • Use the ARRIVE guideline for research on animals in a lab.
    • Use the REFLECT guideline for research on livestock.
  • If you are reporting descriptive data (either alone or alongside quantitative data):
    • Use the COREQ guideline for reporting unstructured interviews and focus groups.
    • Use the CARE guideline for reporting one case study or a series of case studies.
    • Use the SRQR guideline for any other descriptive data (qualitative research).
  • If you are reporting research into diagnosis:
    • Use the STARD guideline if you compared the accuracy of a diagnostic test with an established reference standard test.
    • Use the REMARK guideline if you evaluated the prognostic value of a biomarker.
    • Use the TRIPOD guideline if you developed, validated, or updated a prognostic or diagnostic prediction modelling tool.
  • If you are reporting research on an intervention or treatment on human subjects::
    • Use the TIDIER guideline to fully describe your intervention.
    • Use the CHEERS guideline for an economic evaluation of the interventions.
  • Declaration of interest

    All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts of interest, then please state: “Conflicts of interest: none”. More information: <https://www.elsevier.com/__data/promis_misc/asjsur_coi.pdf>.

    Submission declaration and verification

    Submission of an article implies that the work described has not been published previously, except in the form of an abstract, as part of a published lecture or academic thesis, or as an electronic preprint.

    It also means that the manuscript is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out.

    If accepted, it must not be published elsewhere in the same form, in English, Portuguese or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Ithenticate: <http://www.ithenticate.com/>.

    See “Multiple, redundant or concurrent publication”: <https://www.elsevier.com/editors/perk/multiple-duplicate-concurrent-publication-simultaneous-submission>.

    Preprint

    At the discretion of the Editorial board, preprints can be shared any time and will not count as prior publication.

    Use of inclusive language

    Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Authors should make no assumptions about the beliefs or commitments of any reader. The text should present nothing that might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using “he or she”, “his/her” instead of “he” or “his”, and by making use of job titles that are free of stereotyping (e.g. “chairperson” instead of “chairman” and “flight attendant” instead of “stewardess”).

    AUTHORSHIP

    BJAN adopts ICMJE criteria for authorship: <http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html>.

    Each author is required to declare his or her individual contribution to the article. All authors must have materially participated in the research and/or article preparation, so roles for all authors should be described. The statement that all authors have approved the final article should be true and included in the disclosure statement.

    Authors contributions

    All authors should have made substantial contributions to all of the following:

    1. The conception and design of the study, or acquisition of data, or analysis and interpretation of data;
    2. Drafting the article or revising it critically for important intellectual content;
    3. Final approval of the version to be submitted.

    Indicate all affiliations with a lower-case superscript letter immediately after the author’s name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and the e-mail address of each author. If an author has moved since the work described in the article was done, or was visiting at the time, a “Present address” (or “Permanent address”) may be indicated as a footnote to that author’s name. The address at which the author actually did the work must be retained, as the main affiliation address. Superscript Arabic numerals are used for such footnotes. Author affiliations should be presented in increasing hierarchical order (e.g. Disciplina de Anestesiologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo) and should be written as established in its own language (e.g. Université Paris-Sorbonne; Harvard University, Universidade de São Paulo).

    The ORCID (Open Researcher and Contributor ID) must be inserted in all authors’ profiles during the submission process. If any authors do not have an ORCID, they can be registered at <https://orcid.org/register>. Please note that articles with missing ORCID’S will NOT be published.

    Changes to authorship

    Authors are expected to consider the list and order of authors carefully before submitting their manuscript and provide the definitive list at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made before the manuscript has been accepted and only if approved by the journal Editor-in-chief. To request such a change, the Editor-in-chief must receive the following from the corresponding author:

    1. The reason for the change in the author list and
    2. Written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed

    Only in exceptional circumstances the Editor-in-chief will consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor-in-chief considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor-in-chief will result in a corrigendum.

    Copyright

    Along with the submission process, authors will be asked to complete the Journal Publishing Agreement <https://www.elsevier.com/about/policies/copyright>. This document includes any tables, illustrations or other material submitted for publication as part of the manuscript, in all forms and media (whether now known or later developed) throughout the world, in all languages, for the full term of copyright, effective when the Article is accepted for publication. An e-mail will be sent to the corresponding author confirming receipt of the submitted manuscript with a ‘Journal Publishing Agreement” form or a link to the online version of this agreement.

    SUBMISSION OF THE ARTICLE/ MANUSCRIPT

    Online submission plataform

    Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files into a single PDF file used in the peer review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the editor’s decision and requests for revision, is sent by e-mail.

    Submit your article: <http://www.evise.com/evise/jrnl/BJAN>.

    Double-blind review

    BJAN operates a double-blind review process, so remove all data that can identify you or your institution from the text. Reviewers will not know who is responsible for the work when they are reviewing, and the authors will not know who has reviewed their manuscript in any stage of the publication process as well. Thus, the manuscript should not include any identifying information, such as the authors’ names or affiliations.

    All peer reviewers will be initially assessed by the Editor-in-chief for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of atwo independent expert reviewers to assess the scientific quality of the paper. The Editor-in-chief is responsible for the final decision regarding acceptance or rejection of articles and his or her decision is final.

    Use of Word processing software

    It is important that the manuscript file be saved in the native format of the Word processor used. The text should be in single column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article.

    In particular, do not use the Word processor’s options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.

    The electronic text should be prepared in a way very similar to conventional manuscripts (see also the Guide to Publishing with Elsevier: <https://www.elsevier.com/authors/journal-authors/submit-your-paper>. Note that source files of figures, tables and text graphics will be required if you embed your figures in the text.

    To avoid unnecessary errors, you are strongly advised to use the “spell-check” and “grammar-check” functions of your Word processor.

    If English is not your native language and the Editor-in-chief asks you to revise orthography of your text, please submit your article for grammar correction of a qualified company, such as American Journal Experts (AJE), Enago and Proof-Reading-Service (PRS), before acceptance for publication. You can also do that before submitting your text for the first time if it makes you feel more comfortable, even if English is your native language.

    The editor may require a linguistic revision of the articles submitted in Portuguese or adapted to Brazilian Portuguese (e.g. Keimelion, Atha Editorial, GN1).

    Cover letter

    An accompanying succinct cover letter should be submitted for every manuscript, focusing on the novelty and value of the author’s work, the relation to the scope of BJAN, and stating why the editor should consider the article for publication.

    The cover letter will not be part of the final published manuscript.

    Title page

    The title page should include:

    • The actual title and the running title: the title must be concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae if you can. Write the title in the simplest way possible, thinking, “how would I search for this subject in a database or on the internet?”. Do not forget to add the study design in the title, for instance: “randomized clinical trial”, “case report”, “prospective cohort study”, “systematic review”, “narrative review”, among others. Suggest a running or short title, which can be used at the discretion of the Editorial Board.
    • Authorship: must contain details of author’s contributions. Describe names and affiliations of all authors, including the ORCID and e-mail. Clearly indicate given name(s) and family name(s) of each author and check that the spelings for all names are accurate. Please, do not abbreviate authors’ names. Present authors’ affiliation addresses (where the actual work was done). See above more details about authorship and copyright
    • Corresponding author: clearly indicate who will handle correspondence at all stages of refereeing, publication and post-publication. This responsibility includes answering any future queries regarding the study or the report. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.

    Abstract

    An abstract, with the headings background, methods, results and conclusion, should provide the context for the research and state its purpose, basic procedures (selection of study subjects or laboratory animals, observational and analytical methods), main findings (giving specific effect sizes and their statistical significance, if possible), and main conclusions. It should emphasize new and important aspects of the study or observations. Immediately after the abstract, provide a maximum of six keywords in alphabetical order and separated by commas, to represent the content of the article. A specific reporting guideline for abstracts is available at EQUATOR Network. The descriptors or keywords should be based on the Health Science Descriptors (Descritores em Ciências da Saúde, DECS), which are available at <http://www.decs.bvs.br> or on the Medical Subject Headings (MeSH): <www.nlm.nih.gov/mesh/MBrowser.html>.

    Article structure

    Manuscripts should be subdivided into clearly defined and unnumbered sections. Each subsection must have a brief heading. Each heading should appear on its own separate line.

    Introduction

    Provide adequate background, avoiding a detailed literature survey or a summary of the results. Specify the hypothesis which justifies the study. State the objectives of the trial.

    Material and methods

    Provide sufficient detail to allow the work to be reproduced. Methods already published in detail elsewhere should be indicated by a reference citation. However, the authors should describe the methods concisely, assuming that the reader might not have access to the original protocol publication, especially if it is not open access. All modifications from the study protocol should be described.

    Results

    Results should be clear, concise and contextualized. Avoid the repetition of data in the text and in the tables or figures.

    Discussion

    In this subsection, explore the significance of the results of the study, do not repeat them. Confront your data with previous findings, avoiding extensive citations and discussion of already published literature. Discuss the limitations of the study and critically justify them. Emphasize the importance of the study for the current state of art as well as the future perspectives related to the study.

    Conclusions

    The main conclusions of the study should be presented in a short Conclusions section.

    Acknowledgements

    Collate acknowledgements in a separate section at the end of the article, before the references. List those individuals who provided help during the research (e.g., providing language help, writing assistance or proofreading the article, etc.).

    References

    All references must be presented according to the Vancouver Style, as you can see below, or by accessing the website of the International Committee of Medical Journal Editors, available at <http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html#g>. Only the references used in the text, numbered in Arabic numerals and in the order in which they were quoted, should be indicated.

    Citation in text

    Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list but may be mentioned in the text.

    If these references are included in the reference list, they should follow the standard reference style of the journal and should include a substitution of the publication date with either “Unpublished results” or “Personal communication”.

    Citation of a reference as “in press” implies that the item has been accepted for publication.

    Reference links

    Increased discoverability of research and high-quality peer review are ensured by online links to the sources cited. In order to allow us to create links to abstracting and indexing services, such as Scopus, CrossRef and PubMed, please ensure that the data provided in the references are correct.

    Note that incorrect surnames, journal/book titles, publication year and pagination may prevent link creation. When copying references, please be careful as they may already contain errors. Use of the DOI is encouraged and can be adopted to cite and link to electronic articles when an article is in press and full citation details are not yet known, but the article is available online.

    A DOI is guaranteed never to change, so you can use it as a permanent link to any electronic article.

    An example of a citation using DOI for an article not yet in an issue is:

    VanDecar J.C., Russo R.M., James D.E., et al (2003). Aseismic continuation of the Lesser Antilles slab beneath northeastern Venezuela. Journal of Geophysical Research, https://doi.org/10.1029/2001JB000884.

    Please note the format of such citations should be in the same style as all other references in the paper.

    Web references

    The full URL should be given with the date of when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication etc.), should also be presented.

    Data references

    BJAN encourages you to cite underlying or relevant datasets in your manuscript by making mention of them in your text and including a data reference in your Reference List, which should include the following elements:

    • Author name(s);
    • Dataset title;
    • Data repository;
    • Version (where available);
    • Year;
    • Global persistent identifier;
    • Add [dataset] immediately before the reference so we can properly identify it as a data reference. This identifier will not appear in your published article.

    References in a special issue

    Please ensure that the words ‘this issue’ are added to any references in the list (and any citations in the text) to other articles in the same Special Issue.

    Reference style

    Text: Indicate references by superscript numbers in the text. The actual authors can be referred to, but the reference number(s) must always be given.

    List: Number the references in the list in the order in which they appear in the text.

    Examples:

    Reference to a journal publication:
    Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun. 2010;163:51–9. https://doi.org/10.1016/j.Sc.2010.00372.

    Reference to a journal publication with an article number:
    Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. Heliyon. 2018;19:e00205. https://doi.org/j.heliyon.2018.e00205.

    Reference to a book:
    Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000.

    Reference to a chapter in an edited book:
    Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age. New York: E-Publishing Inc; 2009, p. 281–304.

    Reference to a website:
    Cancer Research UK. Cancer statistics reports for the UK, https://www.cancerreearchuk.org/aboutcancer/statistics/cancestatsreport [accessed 13 March 2003].

    Reference to a dataset:
    [dataset] 6. Oguro M, Imahiro S, Saito S, et al. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015. https://doi.org/10.17632/xwj98nb39r.1.

    Note: use shortened form for last page number. e.g., 51–9, and for more than 6 authors, the first 3 should be listed followed by “et al.”.

    Journal abbreviations source

    Journal names should be abbreviated according to the List of Title Word Abbreviations: <https://www.elsevier.com/__data/promis_misc/BMCL_Abbreviations.pdf>

    Funding sources

    You are requested to identify who provided financial support and briefly describe the role of the sponsor(s). If the funding source(s) had no such involvement, then it should be stated as well.

    List funding sources in a standard format to facilitate compliance to funder’s requirements.

    For instance: This work was supported by the CNPq [grant number xxxx] and FAPESP [grant number xxxx].

    It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding. If no funding has been provided for the research, please include the following sentence: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

    Abbreviations

    Define abbreviations that are not standard in this field in the first presentation in the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there. Ensure consistency of abbreviations throughout the article.

    Units

    Follow internationally accepted rules and conventions. Use the international system of units (SI). If other units are mentioned, please give their equivalent in SI.

    Footnotes

    Footnotes should be used sparingly. Use of references is preferable.

    Artwork

    Image manipulation

    In the process of acceptance, the authors sometimes need to manipulate images for clarity, although editing for purposes of deception or fraud will be seen as scientific ethical abuse and will be dealt with accordingly.

    For graphical images, BJAN applies the following policy: no specific feature within an image may be enhanced, obscured, moved, removed, or introduced. Adjustments of brightness, contrast, or color balance are acceptable if and as long as they do not obscure or eliminate any information present in the original. Nonlinear adjustments (e.g. changes to gamma settings) must be disclosed in the figure legend.

    Before submitting any kind of images or graphics, be sure that the resolution of the material is proper for printing and publishing (300 dpi). You can confirm this data in the image details. If your image is less than 300 dpi, it will not be printed properly and will not be accepted. If it is 300 dpi or more you can submit it promptly

    Electronic artwork

    • Make sure you use uniform lettering and sizing in your original artwork;
    • Preferred fonts are Arial (or Helvetica), Times New Roman (or Times), Symbol, and Courier;
    • Number the illustrations according to their sequence in the text;
    • Use a logical naming convention for your artwork files;
    • Indicate, per figure, if it is a single, 1.5 or 2-column fitting image;
    • For Word submissions only, you may still provide figures and their captions, and tables within a single file at the revision stage;
    • Please note that individual figure files larger than 10 MB must be provided in separate source files;
    • A detailed guide on electronic artwork is available: <https://www.elsevier.com/authors/author-schemas/artwork-and-media-instructions>.
    • Formats: Regardless of the application used, when your electronic artwork is finalized, please ‘save as’ or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
    • EPS (or PDF): Vector drawings. Embed the font or save the text as ‘graphics’;
    • TIFF (or JPG): Color or grayscale photographs. For halftones, always use a minimum of 300 dpi;
    • TIFF (or JPG): Bitmapped line drawings: use a minimum of 1000 dpi;
    • TIFF (or JPG): Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
    • Do not:
      • Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
      • Supply files that are too low in resolution;
      • Submit graphics that are disproportionately large for the content.

    Color artwork

    Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF), or MS Office files and with the correct resolution. If, with your accepted article, you submit usable color figures then the journal will ensure, at no additional charge, that these figures will appear in color online only (e.g., ScienceDirect and other sites). The illustrations in color online will be reproduced black & white only in the printed version. The authors should assure the resolution of both colored and black & white illustrations before publication.

    Illustration services

    Elsevier’s WebShop offers Illustration Services to authors preparing to submit a manuscript and concerned about the quality of the images accompanying their article. It can produce scientific, technical and medical-style images, as well as a full range of charts, tables and graphs. It can also improve your images to a professional standard.

    Figure captions

    Ensure that each illustration has a caption. Supply captions separately, not attached to figures. A caption should comprise a brief title – not on the figure itself – and a description of the illustration. Keep text in the illustrations themselves to a minimum, but explain all symbols and abbreviations used.

    Tables

    Please submit tables as editable text and not as images. Tables can be placed either next to the relevant text in the article, or on separate pages at the end. Number tables consecutively in accordance with their appearance in the text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules.

    Video data

    Video material and animation sequences are accepted to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include links to these within the body of the article.

    This can be done in the same way as a figure or table, by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labelled so that they directly relate to the video file’s content.

    In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file formats with a preferred maximum size of 150 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect.

    Please supply stills with your files. You can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data.

    Note: since video and animation cannot be embedded in the printed version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content.

    Supplementary material

    Supplementary material can support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips and more. Please note that such items are published online exactly as they are submitted; there is no typesetting involved (supplementary data supplied as an Excel file or as a PowerPoint slide will appear as such online). Please submit the material with the article and supply a concise and descriptive caption for each file. If you wish to make any changes to supplementary data during any stage of the process, then please make sure to provide an updated file, and do not annotate any corrections on a previous version. Please also make sure to switch off the “Track Changes” option in any Microsoft Office file, as these will appear in the published supplementary file. See below for more details about research data repository.

    Research data

    BJAN encourages you to share data that supports your research publication in an appropriate data repository and enables you to interlink the data with your published articles.

    If you are sharing data, you are encouraged to cite it in your manuscript and reference list. Please refer to the “References” section for more information about data citation.

    Research data refers to the results of observations or experimentation that validate research findings. To facilitate reproducibility and data reuse, this journal also encourages you to share your software, code, models, algorithms, protocols, methods and other useful materials related to the project.

    For more information on depositing, sharing and using research data and other relevant research materials, visit <https://www.elsevier.com/about/policies/research-data>.

    Data linking

    If you have made your research data available in a data repository, you can link your article directly to the dataset. BJAN collaborates with a number of repositories to link articles on ScienceDirect and others, providing readers access to underlying data that give them a better understanding of the research described

    There are different ways to link your datasets to your article. When available, you can directly link them by providing the relevant information in the submission system. For more instructions, visit: <https://www.elsevier.com/authors/author-resources/research-data/data-base-linking>.

    For supported data repositories, a repository banner will automatically appear next to your published article on ScienceDirect. In addition, you can link to relevant data or entities through identifiers within the text of your manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; CCDC: 734053; PDB: 1XFN).

    Data statement

    To foster transparency, we encourage you to state the availability of your data in your submission. If your data is unavailable for access or unsuitable to post, this gives you the opportunity to indicate why. If you submit this form with your manuscript as a supplementary file, the statement will appear next to your published article on ScienceDirect.

    AFTER ACCEPTANCE

    Proofs

    One set of page proofs will be sent by e-mail to the corresponding author or a link will be provided in the e-mail so that authors can access the files themselves.

    Please use this proof only for checking typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the editor.

    We will do everything possible to get your article published quickly and accurately. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility.

    Track your submitted article:
    <https://service.elsevier.com/app/answers/detail/a_id/12237/supporthub/publishing/>

    Track your accepted article:
    <https://authors.elsevier.com/tracking/landingpage/selection.do>

    OPEN ACCESS

    This journal is peer reviewed with subsidized open access, given the Brazilian Society of Anesthesiology (SBA) pays for the publishing costs incurred by the journal. Authors do not have to pay for any Article Processing Charge or Open Access Publication Fee.

    Permitted third party (re)use is defined by the following Creative Commons user licenses: Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) is for non-commercial purposes, to let others distribute and copy the article, and to include in collective work (such as an anthology), as long as they credit the author(s) and prove they do not alter or modify the article.

    Author rights

    As an author, you (or your employer or institution) have certain rights to reuse your work. More information: <https://www.elsevier.com/__data/assets/pdf_file/0007/55654/AuthorUserRights.pdf>

    Responsible sharing

    Find out how you can share your research article published in this journal: <https://www.elsevier.com/about/policies/sharing>.

Idiomas
Brazilian Journal of Anesthesiology (English Edition)

Subscribe to our newsletter

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.